1. Taxonomy of Strategies
Evaluation of Access Accelerated

2. Community Strategies
Community Awareness and Linkage to Care

3. Strategy: Community Awareness and Linkage to Care
Definition: Programs that provide communities and patients with health-related information on disease prevention and treatment, or improve links between patients and the health care system.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Planning
Planning sessions
Reports/briefs
Staff time spent planning
Patients properly diagnosed
Communi-cation
Media
Meetings
Materials
Population exposed
Knowledge of disease symptoms
Patients on appropriate treatment
Population health
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Knowledge of treatment options
Patients retained in care
Population satisfaction
Tech.
Tools
Information systems
Tools in use
Time from first symptom to diagnosis
Adoption of preventive health behaviors
Household financial risk protection
Time from diagnosis to treatment initiation
Mobili-
zation
Community group support
Groups supported
Health care use
Time from treatment initiation to lost-to-follow-up
Funding
Cash donations
Loans
Grants
Funding provided

4. System Strategies Health Service Strengthening Health Service Delivery
Supply Chain
Financing
Regulation and Legislation

5. Strategy: Health Service Strengthening
Definition: Programs designed to improve the availability, affordability, and quality of health services. Common activities include planning, training, infrastructure, technology, management, or funding activities.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Planning
Planning sessions
Reports/briefs
Staff time spent planning
Training
Training sessions
Training materials
Mentorship
Trainees
Health provider knowledge
Population health
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Patients properly diagnosed
Population satisfaction
Patients on appropriate treatment
Tech.
Tools
Information systems
Tools in use
Population access to health services
Patients retained in care
Household financial risk protection
Mgmt.
Procedures
Management systems
Procedures in use
Cost/efficiency of health service delivery
Funding
Cash donations
Loans
Grants
Funding provided

6. Screening Diagnosis Treatment Retention
Strategy: Health Service Delivery
Definition: Programs designed to deliver health services directly to patients. Common activities include screening, diagnosis, treatment, and retention
Inputs
Activities
Outputs
Outcomes
Impact
Short
Short
Medium/Long
Medium/Long
Screening
Screening tests or procedures
Population screened
Patients properly diagnosed
Patients on appropriate treatment
Diagnosis
Diagnostic procedures
Patients properly diagnosed
Population health
Time from first symptom to diagnosis
Value of resources
Staff time
Time from diagnosis to treatment initiation
Population satisfaction
Treatment
Treatment services
Patients on appropriate treatment
Cost/efficiency of treatment services
Patients retained in care
Household financial risk protection
Retention
Retention programs
Patients retained in care
Time from treatment initiation to lost-to-follow-up
Adherence to treatment

7. Strategy: Supply Chain
Definition: Programs designed to improve medicine supply chains, to improve availability and lower costs. Common activities include planning, training, infrastructure, technology, management, or funding activities.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Planning
Planning sessions
Reports/briefs
Staff time spent planning
Training
Training sessions
Training materials
Mentorship
Trainees
Continuity in supply chain
Population health
Availability of medicines at outlets
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Quality of supply chain data
Population satisfaction
Volume of expired medicines
Tech.
Tools
Information systems
Tools in use
On-time medicine stock delivery
Cost/efficiency of supply chain
Household financial risk protection
Mgmt.
Procedures
Management systems
Procedures in use
Funding
Cash donations
Loans
Grants
Funding provided

8. Patients properly diagnosed
Strategy: Financing
Definition: Programs designed to improve health financing systems and reduce catastrophic health expenditure. Common activities include planning, training, infrastructure, technology, management, or funding activities.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Planning
Planning sessions
Reports/briefs
Staff time spent planning
Patients properly diagnosed
Training
Training sessions
Training materials
Mentorship
Trainees
Patients on appropriate treatment
Population health
Treatments and services covered by financing scheme
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Patients retained in care
Population satisfaction
Population access to financing scheme
Population enrolled in financing scheme
Tech.
Tools
Information systems
Tools in use
Household out-of-pocket expenditure: total health
Cost/efficiency of administering financing scheme
Household financial risk protection
Mgmt.
Procedures
Management systems
Procedures in use
Household out-of-pocket expenditure: medicine/treatment
Funding
Cash donations
Loans
Grants
Funding provided
Adoption of preventive health behaviors

9. Strategy: Regulation and Legislation
Definition: Programs designed to improve and harmonize pharmaceutical regulatory systems, improve government coverage of and access to treatments, and/or improve in-country regulatory processes. Common activities include advocacy, training, infrastructure, technology, management or funding activities.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Advocacy
Media
Meetings
Materials
Population exposed
Medicines registered and withdrawn
Regulator knowledge
Training
Training sessions Training materials
Mentorship
Trainees
Quality of registered medicines
Population health
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Harmonization in regulatory practices
Safety of registered medicines
Population satisfaction
Transparency in regulatory process
Tech.
Tools
Information systems
Tools in use
Registration process duration
Household financial risk protection
Availability of medicines at outlets
Mgmt.
Procedures
Management systems
Procedures in use
Meeting target Medicines Regulatory Authority (MRA) performance standards
Population access to health services
Funding
Cash donations
Loans
Grants
Funding provided
Stakeholder awareness of program
Patients on appropriate treatment

10. Production Strategies
Manufacturing
Drug Development Research
Licensing Agreement

11. Strategy: Manufacturing
Definition: Programs designed to build capacity for medicine production. Common activities include planning, training, infrastructure, technology, management, or funding activities.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Planning
Planning sessions
Reports/briefs
Staff time spent planning
Medicines approved and reaching market
Training
Training sessions
Training materials
Mentorship
Trainees
Population health
Volume of medicines sold
Price of medicines at outlets
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Population satisfaction
Quality of medicines
Availability of medicines at outlets
Tech.
Tools
Information systems
Tools in use
Manufacturers participating in national tenders
Patients on appropriate treatment
Household financial risk protection
Mgmt.
Procedures
Management systems
Procedures in use
Tender medicine prices
Funding
Cash donations
Loans
Grants
Funding provided

12. Strategy: Drug Development Research
Definition: Programs designed to support drug development research through planning, training, infrastructure, technology, management, or funding activities. Relevant research areas include bench science, pre-clinical and clinical trials, and post-marketing monitoring.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Planning
Planning sessions
Reports/briefs
Staff time spent planning
Training
Training sessions
Training materials
Mentorship
Trainees
Researcher knowledge
Population health
Studies conducted
Value of resources
Staff time
Infra-structure
Building construction
Equipment donation
Buildings/equipment in use
Molecules screened
Population satisfaction
Tech.
Tools
Information systems
Tools in use
New preclinical candidates
Researcher/institutions affiliated
Household financial risk protection
New medicines/products
Mgmt.
Procedures
Management systems
Procedures in use
Local and international research funding from external funders
Funding
Cash donations
Loans
Grants
Funding provided

13. Voluntary Agreement Patent Enforcement Technology
Strategy: Licensing Agreement
Definition: Programs designed to support local manufacture, importation, sale or use of medicines through legally binding relationships including voluntary agreements and technology sharing.
Inputs
Activities
Outputs
Outcomes
Impact
Voluntary Agreement
Voluntary agreements for generic manufacture, importation of APIs, finished dosage forms
Licenses granted to patent pools
Licenses granted to manufacturers
Short
Medium/Long
Licenses granted
Medicines approved and reaching market
Population health
Price of medicines at outlets
Value of resources
Staff time
Patent Enforcement
Not enforcing patents
Immunity-from-suit agreements
Patents not enforced
Volume of medicines sold
Population satisfaction
Availability of medicines at outlets
Quality of medicines
Patients on appropriate treatment
Household financial risk protection
Technology
Sharing technical knowledge on manufacturing etc. of APIs or finished dosage form
Sharing data for market authorization
Companies benefiting from technology sharing
Medicine production costs

14. Price Strategies
Price Scheme
Medicine Donation

15. Strategy: Price Scheme
Definition: Programs designed to increase the affordability of medicines for individuals and healthcare systems through a reduction in the price via subsidies or other means (excluding donations).
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Pricing
Price scheme
Differential pricing
Subsidies
Vouchers
Bundling (e.g., buy-one-get- one-free)
Volume of medicines sold
Price of medicines at outlets
Availability of medicines at outlets
Household out-of-pocket expenditure: total health
Population health
Delivery
Value of resources
Staff time
Delivery of price scheme medicines to patients
Number of patients reached
Household out-of-pocket expenditure: medicine/treatment
Cost/efficiency of service delivery
Population satisfaction
Patients on appropriate treatment
Household financial risk protection
Communication
Communication of program details to
Providers
Patients
Population exposed to communication activities
Patients receiving program medicines
Provider and patient awareness of program

16. Strategy: Medicine Donation
Definition: Programs designed to increase the availability and/or affordability of medicines through direct donation of medicines, and other healthcare products, to countries or health institutions or non-governmental organizations. Does not include compassionate access programs.
Inputs
Activities
Outputs
Outcomes
Impact
Short
Medium/Long
Donation
Medicine donated
Volume of medicines Donated
Value of medicines donated
Price of medicines at outlets
Availability of medicines at outlets
Household out-of-pocket expenditure: total health
Population health
Delivery
Value of resources
Staff time
Delivery of donated medicines to patients
Number of patients receiving donated products
Household out-of-pocket expenditure: medicine/treatment
Cost/efficiency of service delivery
Population satisfaction
Patients on appropriate treatment
Household financial risk protection
Communication
Communication of details of donation program
Population exposed to communication activities
Patients receiving program medicines
Provider and patient awareness of program